{
    "2019-07-23": [
        [
            {
                "time": "",
                "original_text": "战略大猜想（上）恒瑞医药、阿斯利康中国等头部医药企业的战略洞察",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "阿斯利康",
                        "头部企业",
                        "战略洞察"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "《财富》世界500强 11家药企上榜（附名单）",
                "features": {
                    "keywords": [
                        "财富",
                        "世界500强",
                        "药企",
                        "上榜"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "数据王：上周重要数据盘点",
                "features": {
                    "keywords": [
                        "数据王",
                        "上周",
                        "重要数据",
                        "盘点"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "明星基金经理业绩分析之：兴全董承非 FOF系列研究之 八",
                "features": {
                    "keywords": [
                        "明星基金经理",
                        "兴全",
                        "董承非",
                        "FOF",
                        "业绩分析"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业: 健康中国行动正式开展，科创板上市在即",
                "features": {
                    "keywords": [
                        "医药生物",
                        "健康中国",
                        "行动",
                        "科创板",
                        "上市"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业盘前早知道: 拥抱确定性, 波动加剧分化",
                "features": {
                    "keywords": [
                        "医药行业",
                        "盘前",
                        "确定性",
                        "波动",
                        "分化"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业跨市场周报: 仿制药价格体系加速重塑, 药企迈向体系竞争时代",
                "features": {
                    "keywords": [
                        "医药生物",
                        "跨市场",
                        "仿制药",
                        "价格体系",
                        "重塑",
                        "体系竞争"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}